125 related articles for article (PubMed ID: 26071354)
1. MicroRNA-101 down-regulates sphingosine kinase 1 in colorectal cancer cells.
Chen MB; Yang L; Lu PH; Fu XL; Zhang Y; Zhu YQ; Tian Y
Biochem Biophys Res Commun; 2015 Aug; 463(4):954-60. PubMed ID: 26071354
[TBL] [Abstract][Full Text] [Related]
2. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
3. Targeting sphingosine kinase 2 (SphK2) by ABC294640 inhibits colorectal cancer cell growth in vitro and in vivo.
Xun C; Chen MB; Qi L; Tie-Ning Z; Peng X; Ning L; Zhi-Xiao C; Li-Wei W
J Exp Clin Cancer Res; 2015 Sep; 34(1):94. PubMed ID: 26337959
[TBL] [Abstract][Full Text] [Related]
4. Targeting colorectal cancer cells by a novel sphingosine kinase 1 inhibitor PF-543.
Ju T; Gao D; Fang ZY
Biochem Biophys Res Commun; 2016 Feb; 470(3):728-734. PubMed ID: 26775841
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo.
Yang S; Li W; Sun H; Wu B; Ji F; Sun T; Chang H; Shen P; Wang Y; Zhou D
BMC Cancer; 2015 Dec; 15():969. PubMed ID: 26674205
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y
Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162
[TBL] [Abstract][Full Text] [Related]
7. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH
Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020
[TBL] [Abstract][Full Text] [Related]
8. miR-124 inhibits cell proliferation in gastric cancer through down-regulation of SPHK1.
Xia J; Wu Z; Yu C; He W; Zheng H; He Y; Jian W; Chen L; Zhang L; Li W
J Pathol; 2012 Aug; 227(4):470-80. PubMed ID: 22450659
[TBL] [Abstract][Full Text] [Related]
9. Increased Sphingosine Kinase 1 Expression Predicts Distant Metastasis and Poor Outcome in Patients With Colorectal Cancer.
Bae GE; DO SI; Kim K; Park JH; Cho S; Kim HS
Anticancer Res; 2019 Feb; 39(2):663-670. PubMed ID: 30711943
[TBL] [Abstract][Full Text] [Related]
10. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.
Wang F; Ma YL; Zhang P; Shen TY; Shi CZ; Yang YZ; Moyer MP; Zhang HZ; Chen HQ; Liang Y; Qin HL
J Pathol; 2013 Jan; 229(1):12-24. PubMed ID: 22821729
[TBL] [Abstract][Full Text] [Related]
11. AT7867 Inhibits Human Colorectal Cancer Cells via AKT-Dependent and AKT-Independent Mechanisms.
Zhang S; Deng Z; Yao C; Huang P; Zhang Y; Cao S; Li X
PLoS One; 2017; 12(1):e0169585. PubMed ID: 28081222
[TBL] [Abstract][Full Text] [Related]
12. SphK1 inhibitor II (SKI-II) inhibits acute myelogenous leukemia cell growth in vitro and in vivo.
Yang L; Weng W; Sun ZX; Fu XJ; Ma J; Zhuang WF
Biochem Biophys Res Commun; 2015 May; 460(4):903-8. PubMed ID: 25824043
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
Wang Y; Tang Q; Li M; Jiang S; Wang X
Biochem Biophys Res Commun; 2014 Feb; 444(2):199-204. PubMed ID: 24440701
[TBL] [Abstract][Full Text] [Related]
14. Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense?
Amodeo V; Bazan V; Fanale D; Insalaco L; Caruso S; Cicero G; Bronte G; Rolfo C; Santini D; Russo A
Expert Opin Ther Targets; 2013 Nov; 17(11):1249-61. PubMed ID: 24053448
[TBL] [Abstract][Full Text] [Related]
15. miR-320a suppresses colorectal cancer progression by targeting Rac1.
Zhao H; Dong T; Zhou H; Wang L; Huang A; Feng B; Quan Y; Jin R; Zhang W; Sun J; Zhang D; Zheng M
Carcinogenesis; 2014 Apr; 35(4):886-95. PubMed ID: 24265291
[TBL] [Abstract][Full Text] [Related]
16. MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor.
Shen K; Liang Q; Xu K; Cui D; Jiang L; Yin P; Lu Y; Li Q; Liu J
Biochem Pharmacol; 2012 Aug; 84(3):320-30. PubMed ID: 22580051
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-143 replenishment re-sensitizes colorectal cancer cells harboring mutant, but not wild-type, KRAS to paclitaxel treatment.
Fei BY; Wang XY; Fang XD
Tumour Biol; 2016 May; 37(5):5829-35. PubMed ID: 26581910
[TBL] [Abstract][Full Text] [Related]
18. Angiopoietin-like protein 2 negatively regulated by microRNA-25 contributes to the malignant progression of colorectal cancer.
Zhou J; Wang J; Wu S; Zhu S; Wang S; Zhou H; Tian X; Tang N; Nie S
Int J Mol Med; 2014 Nov; 34(5):1286-92. PubMed ID: 25174582
[TBL] [Abstract][Full Text] [Related]
19. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
